Ares Management Has Decreased Its Fidus Investment (FDUS) Stake; 2 Analysts Covering Nxstage Medical, Inc. (NXTM)

December 7, 2017 - By Henry Gaston

Among 9 analysts covering NxStage Medical (NASDAQ:NXTM), 2 have Buy rating, 1 Sell and 6 Hold. Therefore 22% are positive. NxStage Medical had 18 analyst reports since November 4, 2015 according to SRatingsIntel. The stock has “Hold” rating by Jefferies on Tuesday, August 8. The firm has “Buy” rating by Sterne Agee CRT given on Friday, December 11. Canaccord Genuity maintained it with “Hold” rating and $30.0 target in Monday, October 16 report. Northland Capital maintained Nxstage Medical, Inc. (NASDAQ:NXTM) on Monday, August 7 with “Hold” rating. The stock of Nxstage Medical, Inc. (NASDAQ:NXTM) earned “Buy” rating by BTIG Research on Tuesday, June 6. BTIG Research initiated the stock with “Buy” rating in Friday, December 18 report. The firm has “Hold” rating given on Monday, September 11 by Canaccord Genuity. The firm has “Hold” rating given on Monday, August 7 by Craig Hallum. The rating was maintained by Jefferies on Tuesday, October 10 with “Hold”. The stock of Nxstage Medical, Inc. (NASDAQ:NXTM) has “Outperform” rating given on Tuesday, June 28 by Northland Capital. See Nxstage Medical, Inc. (NASDAQ:NXTM) latest ratings:

16/10/2017 Broker: Canaccord Genuity Rating: Hold New Target: $30.0 Maintain
10/10/2017 Broker: Jefferies Rating: Hold New Target: $30.0 Maintain
11/09/2017 Broker: Canaccord Genuity Rating: Hold New Target: $30.0 Maintain
22/08/2017 Broker: Leerink Swann Old Rating: Outperform New Rating: Market Perform Downgrade
11/08/2017 Broker: BTIG Research Old Rating: Buy New Rating: Neutral Downgrade
08/08/2017 Broker: Jefferies Old Rating: Buy New Rating: Hold Downgrade
07/08/2017 Broker: Canaccord Genuity Rating: Hold Downgrade
07/08/2017 Broker: Northland Capital Rating: Hold New Target: $30.0000 Maintain
07/08/2017 Broker: Craig Hallum Rating: Hold Downgrade
27/06/2017 Broker: Craig Hallum Rating: Buy New Target: $32 Initiates Coverage On

Ares Management Llc decreased Fidus Investment Corp (FDUS) stake by 12.21% reported in 2017Q2 SEC filing. Ares Management Llc sold 44,721 shares as Fidus Investment Corp (FDUS)’s stock rose 1.27%. The Ares Management Llc holds 321,613 shares with $5.41M value, down from 366,334 last quarter. Fidus Investment Corp now has $391.15 million valuation. It closed at $15.97 lastly. It is up 12.11% since December 7, 2016 and is uptrending. It has underperformed by 4.59% the S&P500.

Analysts await Fidus Investment Corporation (NASDAQ:FDUS) to report earnings on March, 1. They expect $0.37 earnings per share, down 5.13% or $0.02 from last year’s $0.39 per share. FDUS’s profit will be $9.06 million for 10.79 P/E if the $0.37 EPS becomes a reality. After $0.38 actual earnings per share reported by Fidus Investment Corporation for the previous quarter, Wall Street now forecasts -2.63% negative EPS growth.

Investors sentiment increased to 2.21 in 2017 Q2. Its up 0.34, from 1.87 in 2017Q1. It increased, as 2 investors sold FDUS shares while 12 reduced holdings. 12 funds opened positions while 19 raised stakes. 6.78 million shares or 17.45% more from 5.78 million shares in 2017Q1 were reported. Muzinich accumulated 1.49% or 1.01M shares. Opus Gru Limited Liability Company has invested 0.74% in Fidus Investment Corporation (NASDAQ:FDUS). Buckhead Capital Mgmt Ltd holds 0.49% of its portfolio in Fidus Investment Corporation (NASDAQ:FDUS) for 159,865 shares. Bb&T Secs Limited reported 0.04% in Fidus Investment Corporation (NASDAQ:FDUS). Cibc Mkts holds 0% of its portfolio in Fidus Investment Corporation (NASDAQ:FDUS) for 10,542 shares. 260,347 were accumulated by Sumitomo Mitsui Asset Mgmt Com Ltd. Van Eck Assoc holds 0.02% or 183,155 shares. Royal Bank Of Canada reported 0% stake. Raymond James Trust Na stated it has 0.03% of its portfolio in Fidus Investment Corporation (NASDAQ:FDUS). Yorktown Mngmt And Rech invested in 1.29% or 240,000 shares. Bragg Finance Advsr Incorporated holds 0.03% in Fidus Investment Corporation (NASDAQ:FDUS) or 13,011 shares. Carroll Fincl Inc, North Carolina-based fund reported 5,960 shares. Commonwealth Equity, a Massachusetts-based fund reported 14,826 shares. Manufacturers Life Insurance The owns 588 shares for 0% of their portfolio. Mackenzie invested in 31,381 shares.

Among 5 analysts covering Fidus Investment (NASDAQ:FDUS), 2 have Buy rating, 0 Sell and 3 Hold. Therefore 40% are positive. Fidus Investment had 9 analyst reports since January 15, 2016 according to SRatingsIntel. Oppenheimer maintained the stock with “Buy” rating in Friday, August 4 report. The company was downgraded on Monday, January 9 by Robert W. Baird. On Friday, November 3 the stock rating was maintained by Robert W. Baird with “Hold”. The stock of Fidus Investment Corporation (NASDAQ:FDUS) has “Mkt Perform” rating given on Tuesday, January 10 by Keefe Bruyette & Woods. As per Sunday, July 23, the company rating was maintained by Keefe Bruyette & Woods. Janney Capital initiated Fidus Investment Corporation (NASDAQ:FDUS) on Friday, January 15 with “Neutral” rating. The rating was maintained by Keefe Bruyette & Woods with “Hold” on Wednesday, May 31. On Friday, September 23 the stock rating was initiated by DA Davidson with “Buy”. The company was maintained on Sunday, October 22 by Keefe Bruyette & Woods.

Investors sentiment increased to 1.14 in Q2 2017. Its up 0.10, from 1.04 in 2017Q1. It is positive, as 24 investors sold Nxstage Medical, Inc. shares while 47 reduced holdings. 28 funds opened positions while 53 raised stakes. 58.75 million shares or 4.24% less from 61.35 million shares in 2017Q1 were reported. Nuveen Asset Mngmt holds 136,174 shares or 0.02% of its portfolio. Goldman Sachs Gp Inc Inc owns 100,452 shares. Altrinsic Global Advsr Ltd Liability Co accumulated 426,300 shares. Ameritas Partners holds 0.01% or 5,498 shares. Renaissance Ltd Liability Co reported 14,783 shares or 0% of all its holdings. Glenmede Tru Company Na has invested 0% in Nxstage Medical, Inc. (NASDAQ:NXTM). First Trust Advsrs Lp has 35,611 shares for 0% of their portfolio. Pura Vida Investments Lc invested 2.21% of its portfolio in Nxstage Medical, Inc. (NASDAQ:NXTM). Gp One Trading Limited Partnership reported 10,463 shares or 0% of all its holdings. Northern Tru holds 0.01% or 879,745 shares in its portfolio. Millennium Mgmt Lc holds 0.04% or 971,623 shares in its portfolio. Portolan Mgmt Llc holds 1.58% of its portfolio in Nxstage Medical, Inc. (NASDAQ:NXTM) for 492,188 shares. 429 are owned by Citigroup. Hbk L P holds 0.02% or 71,100 shares in its portfolio. New York State Common Retirement Fund invested in 0% or 68,600 shares.

The stock increased 0.04% or $0.01 during the last trading session, reaching $25.62. About 184,727 shares traded. Nxstage Medical, Inc. (NASDAQ:NXTM) has risen 21.18% since December 7, 2016 and is uptrending. It has outperformed by 4.48% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com